Global Health Limited has released its compliance update for the quarter ended March 31, 2026. In conjunction with its registrar and transfer agent, Kfin Technologies Limited, the company has confirmed that there were no activities regarding the dematerialization or rematerialization of securities during this period. Consequently, no intimation was required to be filed with the depositories or stock exchanges for the quarter.
Quarterly Compliance Summary
Global Health Limited, operating under the brand Medanta, has provided an update on its share transfer and dematerialization status for the final quarter of the financial year, covering the period ending March 31, 2026. The company maintains strict adherence to record-keeping and procedural requirements to ensure transparency for its stakeholders.
Status of Securities Transactions
As confirmed by the company’s Registrar and Transfer Agent, Kfin Technologies Limited, there were nil instances of securities being dematerialized or rematerialized during the January to March 2026 quarter. This status indicates that there was no movement in the physical-to-electronic conversion of shareholding for the company during these three months.
Next Steps
Since the volume of dematerialization and rematerialization requests was zero for the reported quarter, the company was not required to provide any further formal filings to the relevant depositories or stock exchanges regarding this specific activity. This report serves to finalize the company’s administrative compliance obligations for the quarter.
Source: BSE
